Recently published study results showed that the bile acid sequestrant IW-3718 reduced heartburn and regurgitation symptoms in patients with refractory GERD. Further, the 1,500 mg twice-daily dose of ...

Colesevelam (Welchol), a specifically-engineered, non-absorbed polymer that binds bile acids in the intestine thereby impeding their resorption, is approved as an adjunct to diet and exercise to ...

In total, 8 studies evaluated the probability of response to bile acid sequestrants after a positive SeHCAT test at a 15% threshold. Only 2 of these were new studies found through the searches in this ...

Most people have at some point in their life suffered an intestinal infection or food poisoning forcing them to stay close to the bathroom. It is very uncomfortable. Most of the time, though, it ...

A new study confirms a protective effect of statin cholesterol-lowering drugs on liver cancer risk and suggests a similar effect with nonstatin cholesterol absorption inhibitors. Ever use of ...

There's been quite a bit of "noise" in the cholesterol category within the past year -- statins being recalled or relabeled due to safety concerns and future "super statins" now being called into ...

Results inconsistent for association with bile acid sequestrant use depending on diabetes and liver disease status. HealthDay News — The use of cholesterol absorption inhibitors is associated with a ...

Medically reviewed by Kristie Reed, PharmD Key Takeaways You can take a vitamin K at any time of day, in the morning or the evening.Vitamin K is a fat-soluble vitamin. Take it with a high-fat meal to ...

Past studies have suggested that taking cholesterol-lowering statin drugs may lower individuals' risk of developing liver cancer. In a new study of non-statin cholesterol-lowering medications, one ...

High levels of a hormone found in cells in the gut could underlie many cases of chronic diarrhea and help explain up to 40% of cases of patients with irritable bowel syndrome with diarrhea, according ...

Clin Lipidology. 2014;9(6):695-707. Table 1. American Association of Clinical Endocrinologists 2012 Guidelines: lipid-related risks categorized by optimal/near optimal, borderline and high-risk serum ...